Cancer therapies may trigger aging phenotypes in survivors

Cancer therapies may trigger aging phenotypes in survivors

(HealthDay)—Cancer therapies have direct effects on telomere length, epigenetic modifications, and microRNA, which can mimic phenotypes of aging, according to a review published online Dec. 18 in ESMO Open.

Noting that have an earlier onset and increased incidence of chronic comorbidities than the general population, Margaret C. Cupit-Link, from the Mayo Clinic in Rochester, Minn., and colleagues conducted a systematic review to examine the cellular biology of aging and/or mechanisms of cancer therapies similar to aging mechanisms.

The researchers identified multiple biological processes of aging at the cellular level and correlations with cancer therapies and clinical effects. Various chemotherapies and radiation had direct effects on , senescent cells, , and microRNA. Cancer survivors exhibited long-term comorbidities that mimic the phenotypes of aging and may result from the interaction between therapeutic exposures and the underlying biology of aging.

"Long-term follow-up of cancer survivors and research on prevention strategies should be pursued to increase the length and quality of life among the growing population of cancer survivors," the authors write.


Explore further

Risk for aging-related diseases elevated among thyroid cancer survivors

More information: Abstract/Full Text

Copyright © 2017 HealthDay. All rights reserved.

Citation: Cancer therapies may trigger aging phenotypes in survivors (2017, December 19) retrieved 16 September 2019 from https://medicalxpress.com/news/2017-12-cancer-therapies-trigger-aging-phenotypes.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
13 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more